доктор технических наук;
doctor of technical sciences;
Цель: Представление истории, статуса и перспектив развития протонной лучевой терапии. Материал и методы: Представлены обоснования, в т.ч. клинически доказанные, высокой эффективности протонной лучевой терапии (ПЛТ). Изложена история развития ПЛТ, ее быстрое внедрение в мировую клиническую практику, кардинальное расширение сферы использования и прогноз развития. Показан вклад российских исследователей в проблему и критическое отставание российского здравоохранения от общемировых тенденций использования и технологиями развития ПЛТ. Результаты: Выполнен анализ состояния ПЛТ в мире и в России и представлены возможные пути оснащения российского здравоохранения средствами ПЛТ. Заключение: Российское здравоохранение со временем, несомненно, будет оснащено средствами ПЛТ либо зарубежного, либо отечественного производства, причем последний вариант предпочтительней.
Purpose: Presentation of the history, status and prospects for the development of proton therapy. Material and methods: The history of proton therapy (PT) is divided into two periods. The first one – the experimental period lasted since 1954 to 1990, when proton therapy was carried out at the ten facilities in physical institutes. The research accelerators and the horizontal proton beams with a fixed direction are used. The second period is from 1990, when the first clinical proton center was commissioned in a multi-field hospital in the city of Loma Linda, USA. In the first period, the necessary technical tools were developed and the advantages of using accelerated protons in remote radiation therapy formulated by R. Wilson in 1946 were confirmed on a limited (about 9,000) patient population: halving the radiation load on the healthy tissues surrounding the tumor and on the organism as a whole compared to γ- and electron irradiation and high dose gradients at the borders of the dose distributions and the tumors. This allows to increase the dose in the tumor (target), increase the probability of the tumor resorption and at last to irradiate tumors, including small sizes, located near critical organs and structures. By 1990, in three experimental centers in Russia (JINR, ITEP, PNPI) accumulated about 30 % of world clinical experience. Today, more than 70 multi-cabin and several single-cabin clinical based proton therapy centers operate in the world. Almost all centers are equipped with gantry installations for PT for 95 % of patients. Today proton therapy is indicated and is used for the treatment of 10–15 % of all malignancies of cancer incidence structure. Results: Healthcare in Russia needs 10–15 multi-cabin proton (and ion) centers. Currently, there are one experimental PT center in the JINR, where up to 100 patients are exposed pea year. The modern proton center was commissioned at the Medical Institute Sergei Berezin in St. Petersburg with two gantry of company Varian. The IBA proton center in Dimitrovgrad is expected. The single-cabin proton complex of domestic production has been operating in Obninsk since 2017. 20th-century technologies and the horizontal beam (without the possibility of its rotation) are used in this complex for treatment of patients with small head and neck tumors. Conclusion: Equipping the Russian health care facilities with proton therapy facilities is inevitable. Russia will buy them worldwide for decades, like almost all types of high-tech medical equipment, are bought today, or can produce them locally. All the prerequisites needed for production (rich physical – technical experience, scientific and industrial potential) are available.